Loading clinical trials...

Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia | Clinical Trials | Clareo Health

Not Yet RecruitingNANCT06931223

Efficacy of Gut-Brain Neuromodulators for Functional Dyspepsia

The use of Neuromodulators is now recognized by international consensus as effective in improving Disorders of Gut-Brain Interaction (DGBIs). However, the digestive mind-body concept of therapeutic dr...

Lead sponsor: RenJi Hospital•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

Not Yet RecruitingPhase 4

Comparing Acotiamide and Itopride for the Management of Indigestion

NCT07449689 · Functioanl Dyspepsia, Post Prandial Distress Syndrome

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 17, 2025Terms

Trial snapshot

StatusNOT_YET_RECRUITING

PhaseNA

Enrollment200

Start dateApr 2025

Last updatedApr 17, 2025

Condition

Functioanl Dyspepsia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 17, 2025Data synced to Clareo: May 25, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions